Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
No insurance required HSA/FSA receipts available Pricing New patient consult (in-person) Credited to month 1 injectables if you start $49 From $195/mo From $235/mo 3-month injectable prepay Price based on weekly dose see dose tier table From $825 Oral GLP-1 (home delivery) Sublingual semaglutide or tirzepatide delivered to your home $165$279/mo Pharmacy Rx evaluation Rx only med cost at pharmacy separate $150/mo Full treatment details Family-owned, NP-directed, and here longer than most competitors have been open same experienced hands, authentic product, honest pricing
J Diabetes Res 2018:1232583 Ikonomidis I, Pavlidis G, Thymis J, Birba D, Kalogeris A, Kousathana F, Kountouri A, Balampanis K, Parissis J, Andreadou I, Katogiannis K, Dimitriadis G, Bamias A, Iliodromitis E, Lambadiari V (2020) Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on endothelial glycocalyx, arterial function, and myocardial work index in patients with type 2 diabetes mellitus after 12-month treatment
Liraglutide-induced weight loss is blunted by the local injection of a GLP-1R antagonist into the ARC [2]
In 1 study of more than 5,000 people with diabetes, metformin appeared weight-neutral when compared to other diabetes medications
Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, is in clinical trials and will add another option for patients who do not tolerate existing medications
US$ 23.70
US$ 28.19
US$ 27.69
US$ 25.70
